Canada - Probiotic Supplements Market by Disease Type, Type and End-user - Forecast and Analysis 2024-2028

1 Executive Summary

• 1.1 Market overview
  • Exhibit 01: Executive Summary – Chart on Market Overview
  • Exhibit 02: Executive Summary – Data Table on Market Overview
  • Exhibit 03: Executive Summary – Chart on Country Market Characteristics
  • Exhibit 04: Executive Summary – Chart on Market Segmentation by Disease Type
  • Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
  • Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
  • Exhibit 07: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
  • Exhibit 08: Parent market
  • Exhibit 09: Market Characteristics

3 Market Sizing

• 3.1 Market definition
  • Exhibit 10: Offerings of vendors included in the market definition

• 3.2 Market segment analysis
  • Exhibit 11: Market segments

• 3.3 Market size 2023

• 3.4 Market outlook: Forecast for 2023-2028
  • Exhibit 12: Chart on Canada - Market size and forecast 2023-2028 ($ million)
  • Exhibit 13: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
  • Exhibit 14: Chart on Canada: Year-over-year growth 2023-2028 (%)
  • Exhibit 15: Data Table on Canada: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Probiotic supplements market in Canada 2018 - 2022
  • Exhibit 16: Historic Market Size – Data Table on probiotic supplements market in Canada 2018 - 2022 ($ million)

• 4.2 Disease Type Segment Analysis 2018 - 2022
  • Exhibit 17: Historic Market Size – Disease Type Segment 2018 - 2022 ($ million)

• 4.3 Type Segment Analysis 2018 - 2022
  • Exhibit 18: Historic Market Size – Type Segment 2018 - 2022 ($ million)

• 4.4 End-user Segment Analysis 2018 - 2022
  • Exhibit 19: Historic Market Size – End-user Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
  • Exhibit 20: Five forces analysis - Comparison between 2023 and 2028

• 5.2 Bargaining power of buyers
  • Exhibit 21: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028

• 5.3 Bargaining power of suppliers
  • Exhibit 22: Bargaining power of suppliers – Impact of key factors in 2023 and 2028

• 5.4 Threat of new entrants
  • Exhibit 23: Threat of new entrants – Impact of key factors in 2023 and 2028

• 5.5 Threat of substitutes
  • Exhibit 24: Threat of substitutes – Impact of key factors in 2023 and 2028

• 5.6 Threat of rivalry
  • Exhibit 25: Threat of rivalry – Impact of key factors in 2023 and 2028

• 5.7 Market condition
  • Exhibit 26: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Disease Type

• 6.1 Market segments
  • Exhibit 27: Chart on Disease Type - Market share 2023-2028 (%)
  • Exhibit 28: Data Table on Disease Type - Market share 2023-2028 (%)

• 6.2 Comparison by Disease Type
  • Exhibit 29: Chart on Comparison by Disease Type
  • Exhibit 30: Data Table on Comparison by Disease Type

• 6.3 Gastrointestinal diseases - Market size and forecast 2023-2028
  • Exhibit 31: Chart on Gastrointestinal diseases - Market size and forecast 2023-2028 ($ million)
  • Exhibit 32: Data Table on Gastrointestinal diseases - Market size and forecast 2023-2028 ($ million)
  • Exhibit 33: Chart on Gastrointestinal diseases - Year-over-year growth 2023-2028 (%)
  • Exhibit 34: Data Table on Gastrointestinal diseases - Year-over-year growth 2023-2028 (%)

• 6.4 Infectious diseases - Market size and forecast 2023-2028
  • Exhibit 35: Chart on Infectious diseases - Market size and forecast 2023-2028 ($ million)
  • Exhibit 36: Data Table on Infectious diseases - Market size and forecast 2023-2028 ($ million)
  • Exhibit 37: Chart on Infectious diseases - Year-over-year growth 2023-2028 (%)
  • Exhibit 38: Data Table on Infectious diseases - Year-over-year growth 2023-2028 (%)

• 6.5 Others - Market size and forecast 2023-2028
  • Exhibit 39: Chart on Others - Market size and forecast 2023-2028 ($ million)
  • Exhibit 40: Data Table on Others - Market size and forecast 2023-2028 ($ million)
  • Exhibit 41: Chart on Others - Year-over-year growth 2023-2028 (%)
  • Exhibit 42: Data Table on Others - Year-over-year growth 2023-2028 (%)

• 6.6 Market opportunity by Disease Type
  • Exhibit 43: Market opportunity by Disease Type ($ million)
  • Exhibit 44: Data Table on Market opportunity by Disease Type ($ million)

7 Market Segmentation by Type

• 7.1 Market segments
  • Exhibit 45: Chart on Type - Market share 2023-2028 (%)
  • Exhibit 46: Data Table on Type - Market share 2023-2028 (%)

• 7.2 Comparison by Type
  • Exhibit 47: Chart on Comparison by Type
  • Exhibit 48: Data Table on Comparison by Type

• 7.3 Bacteria - Market size and forecast 2023-2028
  • Exhibit 49: Chart on Bacteria - Market size and forecast 2023-2028 ($ million)
  • Exhibit 50: Data Table on Bacteria - Market size and forecast 2023-2028 ($ million)
  • Exhibit 51: Chart on Bacteria - Year-over-year growth 2023-2028 (%)
  • Exhibit 52: Data Table on Bacteria - Year-over-year growth 2023-2028 (%)

• 7.4 Yeast - Market size and forecast 2023-2028
  • Exhibit 53: Chart on Yeast - Market size and forecast 2023-2028 ($ million)
  • Exhibit 54: Data Table on Yeast - Market size and forecast 2023-2028 ($ million)
  • Exhibit 55: Chart on Yeast - Year-over-year growth 2023-2028 (%)
  • Exhibit 56: Data Table on Yeast - Year-over-year growth 2023-2028 (%)

• 7.5 Market opportunity by Type
  • Exhibit 57: Market opportunity by Type ($ million)
  • Exhibit 58: Data Table on Market opportunity by Type ($ million)

8 Market Segmentation by End-user

• 8.1 Market segments
  • Exhibit 59: Chart on End-user - Market share 2023-2028 (%)
  • Exhibit 60: Data Table on End-user - Market share 2023-2028 (%)

• 8.2 Comparison by End-user
  • Exhibit 61: Chart on Comparison by End-user
  • Exhibit 62: Data Table on Comparison by End-user

• 8.3 Human probiotics - Market size and forecast 2023-2028
  • Exhibit 63: Chart on Human probiotics - Market size and forecast 2023-2028 ($ million)
  • Exhibit 64: Data Table on Human probiotics - Market size and forecast 2023-2028 ($ million)
  • Exhibit 65: Chart on Human probiotics - Year-over-year growth 2023-2028 (%)
  • Exhibit 66: Data Table on Human probiotics - Year-over-year growth 2023-2028 (%)

• 8.4 Animal probiotics - Market size and forecast 2023-2028
  • Exhibit 67: Chart on Animal probiotics - Market size and forecast 2023-2028 ($ million)
  • Exhibit 68: Data Table on Animal probiotics - Market size and forecast 2023-2028 ($ million)
  • Exhibit 69: Chart on Animal probiotics - Year-over-year growth 2023-2028 (%)
  • Exhibit 70: Data Table on Animal probiotics - Year-over-year growth 2023-2028 (%)

• 8.5 Market opportunity by End-user
  • Exhibit 71: Market opportunity by End-user ($ million)
  • Exhibit 72: Data Table on Market opportunity by End-user ($ million)

9 Customer Landscape

• 9.1 Customer landscape overview
  • Exhibit 73: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

10 Drivers, Challenges, and Trends

• 10.1 Market drivers

• 10.2 Market challenges

• 10.3 Impact of drivers and challenges
  • Exhibit 74: Impact of drivers and challenges in 2023 and 2028

• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview

• 11.2 Vendor landscape
  • Exhibit 75: Overview on Criticality of inputs and Factors of differentiation

• 11.3 Landscape disruption
  • Exhibit 76: Overview on factors of disruption

• 11.4 Industry risks
  • Exhibit 77: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
  • Exhibit 78: Vendors covered

• 12.2 Market positioning of vendors
  • Exhibit 79: Matrix on vendor position and classification

• 12.3 American Biologics LLC
  • Exhibit 80: American Biologics LLC - Overview
  • Exhibit 81: American Biologics LLC - Product / Service
  • Exhibit 82: American Biologics LLC - Key offerings

• 12.4 Archer Daniels Midland Co.
  • Exhibit 83: Archer Daniels Midland Co. - Overview
  • Exhibit 84: Archer Daniels Midland Co. - Business segments
  • Exhibit 85: Archer Daniels Midland Co. - Key offerings
  • Exhibit 86: Archer Daniels Midland Co. - Segment focus

• 12.5 Biena Inc.
  • Exhibit 87: Biena Inc. - Overview
  • Exhibit 88: Biena Inc. - Product / Service
  • Exhibit 89: Biena Inc. - Key offerings

• 12.6 BioGaia AB
  • Exhibit 90: BioGaia AB - Overview
  • Exhibit 91: BioGaia AB - Business segments
  • Exhibit 92: BioGaia AB - Key news
  • Exhibit 93: BioGaia AB - Key offerings
  • Exhibit 94: BioGaia AB - Segment focus

• 12.7 Biotix Care
  • Exhibit 95: Biotix Care - Overview
  • Exhibit 96: Biotix Care - Product / Service
  • Exhibit 97: Biotix Care - Key offerings

• 12.8 Church and Dwight Co. Inc.
  • Exhibit 98: Church and Dwight Co. Inc. - Overview
  • Exhibit 99: Church and Dwight Co. Inc. - Business segments
  • Exhibit 100: Church and Dwight Co. Inc. - Key offerings
  • Exhibit 101: Church and Dwight Co. Inc. - Segment focus

• 12.9 Genuine Health Inc.
  • Exhibit 102: Genuine Health Inc. - Overview
  • Exhibit 103: Genuine Health Inc. - Product / Service
  • Exhibit 104: Genuine Health Inc. - Key offerings

• 12.10 International Flavors and Fragrances Inc.
  • Exhibit 105: International Flavors and Fragrances Inc. - Overview
  • Exhibit 106: International Flavors and Fragrances Inc. - Business segments
  • Exhibit 107: International Flavors and Fragrances Inc. - Key news
  • Exhibit 108: International Flavors and Fragrances Inc. - Key offerings
  • Exhibit 109: International Flavors and Fragrances Inc. - Segment focus

• 12.11 Jamieson Wellness Inc.
  • Exhibit 110: Jamieson Wellness Inc. - Overview
  • Exhibit 111: Jamieson Wellness Inc. - Business segments
  • Exhibit 112: Jamieson Wellness Inc. - Key news
  • Exhibit 113: Jamieson Wellness Inc. - Key offerings
  • Exhibit 114: Jamieson Wellness Inc. - Segment focus

• 12.12 Kerry Group Plc
  • Exhibit 115: Kerry Group Plc - Overview
  • Exhibit 116: Kerry Group Plc - Business segments
  • Exhibit 117: Kerry Group Plc - Key news
  • Exhibit 118: Kerry Group Plc - Key offerings
  • Exhibit 119: Kerry Group Plc - Segment focus

• 12.13 Koninklijke DSM NV
  • Exhibit 120: Koninklijke DSM NV - Overview
  • Exhibit 121: Koninklijke DSM NV - Business segments
  • Exhibit 122: Koninklijke DSM NV - Key news
  • Exhibit 123: Koninklijke DSM NV - Key offerings
  • Exhibit 124: Koninklijke DSM NV - Segment focus

• 12.14 Lallemand Inc.
  • Exhibit 125: Lallemand Inc. - Overview
  • Exhibit 126: Lallemand Inc. - Product / Service
  • Exhibit 127: Lallemand Inc. - Key offerings

• 12.15 Natural Factors Nutritional Products Ltd.
  • Exhibit 128: Natural Factors Nutritional Products Ltd. - Overview
  • Exhibit 129: Natural Factors Nutritional Products Ltd. - Product / Service
  • Exhibit 130: Natural Factors Nutritional Products Ltd. - Key offerings

• 12.16 NOVA Essentials Inc.
  • Exhibit 131: NOVA Essentials Inc. - Overview
  • Exhibit 132: NOVA Essentials Inc. - Product / Service
  • Exhibit 133: NOVA Essentials Inc. - Key offerings

• 12.17 Reckitt Benckiser Group Plc
  • Exhibit 134: Reckitt Benckiser Group Plc - Overview
  • Exhibit 135: Reckitt Benckiser Group Plc - Business segments
  • Exhibit 136: Reckitt Benckiser Group Plc - Key offerings
  • Exhibit 137: Reckitt Benckiser Group Plc - Segment focus

13 Appendix

• 13.1 Scope of the report

• 13.2 Inclusions and exclusions checklist
  • Exhibit 138: Inclusions checklist
  • Exhibit 139: Exclusions checklist

• 13.3 Currency conversion rates for US$
  • Exhibit 140: Currency conversion rates for US$

• 13.4 Research methodology
  • Exhibit 141: Research methodology
  • Exhibit 142: Validation techniques employed for market sizing
  • Exhibit 143: Information sources

• 13.5 List of abbreviations
  • Exhibit 144: List of abbreviations

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

• Manufacturers and suppliers
• Channel partners
• Industry experts
• Strategic decision makers

Secondary sources

• Industry journals and periodicals
• Government data
• Financial reports of key industry players
• Historical data
• Press releases

DATA ANALYSIS

Data Synthesis

• Collation of data
• Estimation of key figures
• Analysis of derived insights

Data Validation

• Triangulation with data models
• Reference against proprietary databases
• Corroboration with industry experts

REPORT WRITING